

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein maturation by protein folding (GO:0022417) | 5.00993428 |
| 2 | NADH metabolic process (GO:0006734) | 4.96500265 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 4.71313981 |
| 4 | tricarboxylic acid cycle (GO:0006099) | 4.65436232 |
| 5 | biotin metabolic process (GO:0006768) | 4.63314931 |
| 6 | valine metabolic process (GO:0006573) | 4.52203816 |
| 7 | regulation of sequestering of triglyceride (GO:0010889) | 4.35719451 |
| 8 | branched-chain amino acid catabolic process (GO:0009083) | 4.33884330 |
| 9 | fatty acid beta-oxidation (GO:0006635) | 4.31992119 |
| 10 | alpha-linolenic acid metabolic process (GO:0036109) | 4.27307119 |
| 11 | thioester biosynthetic process (GO:0035384) | 4.09575894 |
| 12 | acyl-CoA biosynthetic process (GO:0071616) | 4.09575894 |
| 13 | succinate metabolic process (GO:0006105) | 4.03901378 |
| 14 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.92002294 |
| 15 | fatty acid catabolic process (GO:0009062) | 3.91269993 |
| 16 | acetyl-CoA metabolic process (GO:0006084) | 3.89152904 |
| 17 | branched-chain amino acid metabolic process (GO:0009081) | 3.89034750 |
| 18 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.88533139 |
| 19 | proteasome assembly (GO:0043248) | 3.86873924 |
| 20 | oxaloacetate metabolic process (GO:0006107) | 3.86377408 |
| 21 | fatty acid oxidation (GO:0019395) | 3.85761450 |
| 22 | lipid oxidation (GO:0034440) | 3.83045674 |
| 23 | fatty acid transmembrane transport (GO:1902001) | 3.80983827 |
| 24 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.78652215 |
| 25 | positive regulation of fatty acid oxidation (GO:0046321) | 3.75507719 |
| 26 | carnitine shuttle (GO:0006853) | 3.75274172 |
| 27 | triglyceride catabolic process (GO:0019433) | 3.74570515 |
| 28 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.71302816 |
| 29 | proline biosynthetic process (GO:0006561) | 3.64880321 |
| 30 | regulation of fatty acid oxidation (GO:0046320) | 3.63012866 |
| 31 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.61155058 |
| 32 | tricarboxylic acid metabolic process (GO:0072350) | 3.54099644 |
| 33 | lysine metabolic process (GO:0006553) | 3.53950019 |
| 34 | lysine catabolic process (GO:0006554) | 3.53950019 |
| 35 | triglyceride biosynthetic process (GO:0019432) | 3.53417321 |
| 36 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.52093208 |
| 37 | neutral lipid catabolic process (GO:0046461) | 3.50960216 |
| 38 | acylglycerol catabolic process (GO:0046464) | 3.50960216 |
| 39 | protein retention in ER lumen (GO:0006621) | 3.49149267 |
| 40 | lipid particle organization (GO:0034389) | 3.47929331 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.47683211 |
| 42 | L-phenylalanine metabolic process (GO:0006558) | 3.47683211 |
| 43 | acyl-CoA metabolic process (GO:0006637) | 3.44321532 |
| 44 | thioester metabolic process (GO:0035383) | 3.44321532 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.42811782 |
| 46 | L-phenylalanine catabolic process (GO:0006559) | 3.42811782 |
| 47 | neutral lipid biosynthetic process (GO:0046460) | 3.37403841 |
| 48 | acylglycerol biosynthetic process (GO:0046463) | 3.37403841 |
| 49 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.37268569 |
| 50 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.33906306 |
| 51 | fatty acid homeostasis (GO:0055089) | 3.33337534 |
| 52 | very long-chain fatty acid metabolic process (GO:0000038) | 3.25860815 |
| 53 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.25589015 |
| 54 | monocarboxylic acid catabolic process (GO:0072329) | 3.24958072 |
| 55 | sulfur amino acid catabolic process (GO:0000098) | 3.24719756 |
| 56 | negative regulation of ligase activity (GO:0051352) | 3.23184814 |
| 57 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.23184814 |
| 58 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.21444589 |
| 59 | serine family amino acid biosynthetic process (GO:0009070) | 3.20200714 |
| 60 | brown fat cell differentiation (GO:0050873) | 3.18219031 |
| 61 | establishment of integrated proviral latency (GO:0075713) | 3.11121785 |
| 62 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.10033633 |
| 63 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.09567524 |
| 64 | plasma lipoprotein particle clearance (GO:0034381) | 3.07738256 |
| 65 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.05558872 |
| 66 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.04707634 |
| 67 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.03552142 |
| 68 | coenzyme A metabolic process (GO:0015936) | 3.03462045 |
| 69 | L-serine metabolic process (GO:0006563) | 2.98047188 |
| 70 | 2-oxoglutarate metabolic process (GO:0006103) | 2.96643333 |
| 71 | mitotic nuclear envelope reassembly (GO:0007084) | 2.94801893 |
| 72 | nuclear envelope reassembly (GO:0031468) | 2.94801893 |
| 73 | cellular response to leptin stimulus (GO:0044320) | 2.93936715 |
| 74 | respiratory electron transport chain (GO:0022904) | 2.93254334 |
| 75 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.92486105 |
| 76 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.91620156 |
| 77 | peptidyl-histidine modification (GO:0018202) | 2.91127139 |
| 78 | proline metabolic process (GO:0006560) | 2.90862199 |
| 79 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.89942468 |
| 80 | coenzyme catabolic process (GO:0009109) | 2.89870990 |
| 81 | aspartate family amino acid catabolic process (GO:0009068) | 2.89854935 |
| 82 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.88594667 |
| 83 | cysteine metabolic process (GO:0006534) | 2.88581590 |
| 84 | electron transport chain (GO:0022900) | 2.88397711 |
| 85 | establishment of viral latency (GO:0019043) | 2.88050238 |
| 86 | peroxisome fission (GO:0016559) | 2.87828736 |
| 87 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.86236312 |
| 88 | short-chain fatty acid metabolic process (GO:0046459) | 2.86226939 |
| 89 | tRNA aminoacylation for protein translation (GO:0006418) | 2.84339480 |
| 90 | response to dietary excess (GO:0002021) | 2.84225972 |
| 91 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.83928907 |
| 92 | Golgi transport vesicle coating (GO:0048200) | 2.83349652 |
| 93 | COPI coating of Golgi vesicle (GO:0048205) | 2.83349652 |
| 94 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.83076196 |
| 95 | carnitine transmembrane transport (GO:1902603) | 2.82520579 |
| 96 | GDP-mannose metabolic process (GO:0019673) | 2.82183329 |
| 97 | acylglycerol homeostasis (GO:0055090) | 2.81081185 |
| 98 | triglyceride homeostasis (GO:0070328) | 2.81081185 |
| 99 | COPII vesicle coating (GO:0048208) | 2.79295729 |
| 100 | mitochondrial fusion (GO:0008053) | 2.79203524 |
| 101 | response to leptin (GO:0044321) | 2.78998567 |
| 102 | triglyceride metabolic process (GO:0006641) | 2.78081117 |
| 103 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.77905959 |
| 104 | glycerolipid catabolic process (GO:0046503) | 2.77838398 |
| 105 | NADPH regeneration (GO:0006740) | 2.77807098 |
| 106 | regulation of mitochondrial translation (GO:0070129) | 2.77526978 |
| 107 | cholesterol biosynthetic process (GO:0006695) | 2.76369559 |
| 108 | ventricular cardiac muscle cell development (GO:0055015) | 2.76359029 |
| 109 | alanine transport (GO:0032328) | 2.75778204 |
| 110 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.75090921 |
| 111 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.74262052 |
| 112 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.70715375 |
| 113 | coenzyme A biosynthetic process (GO:0015937) | 2.69962855 |
| 114 | purine ribonucleotide transport (GO:0015868) | 2.69878649 |
| 115 | tRNA aminoacylation (GO:0043039) | 2.69409162 |
| 116 | amino acid activation (GO:0043038) | 2.69409162 |
| 117 | organic acid catabolic process (GO:0016054) | 2.68134438 |
| 118 | carboxylic acid catabolic process (GO:0046395) | 2.68134438 |
| 119 | regulation of triglyceride catabolic process (GO:0010896) | 2.65884422 |
| 120 | regulation of cholesterol metabolic process (GO:0090181) | 2.65110412 |
| 121 | amino-acid betaine transport (GO:0015838) | 2.64483316 |
| 122 | carnitine transport (GO:0015879) | 2.64483316 |
| 123 | regulation of triglyceride metabolic process (GO:0090207) | 2.63759768 |
| 124 | regulation of coenzyme metabolic process (GO:0051196) | 2.63646579 |
| 125 | regulation of cofactor metabolic process (GO:0051193) | 2.63646579 |
| 126 | oxidative phosphorylation (GO:0006119) | 2.63635853 |
| 127 | cullin deneddylation (GO:0010388) | 2.62902386 |
| 128 | L-serine transport (GO:0015825) | 2.62258276 |
| 129 | sterol biosynthetic process (GO:0016126) | 2.61783781 |
| 130 | 4-hydroxyproline metabolic process (GO:0019471) | 2.61554988 |
| 131 | white fat cell differentiation (GO:0050872) | 2.61422498 |
| 132 | acylglycerol metabolic process (GO:0006639) | 2.61218104 |
| 133 | neutral lipid metabolic process (GO:0006638) | 2.61039622 |
| 134 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.61018412 |
| 135 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.60906945 |
| 136 | amyloid precursor protein catabolic process (GO:0042987) | 2.59913565 |
| 137 | pantothenate metabolic process (GO:0015939) | 2.59380675 |
| 138 | protein deneddylation (GO:0000338) | 2.58016393 |
| 139 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.57536473 |
| 140 | cellular ketone body metabolic process (GO:0046950) | 2.55904720 |
| 141 | pentose-phosphate shunt (GO:0006098) | 2.54564945 |
| 142 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.54315494 |
| 143 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.53836364 |
| 144 | positive regulation of lipid catabolic process (GO:0050996) | 2.53194405 |
| 145 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.52857662 |
| 146 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.52857662 |
| 147 | quinone biosynthetic process (GO:1901663) | 2.52095802 |
| 148 | de novo protein folding (GO:0006458) | 2.49734065 |
| 149 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.49066300 |
| 150 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.49066300 |
| 151 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.49066300 |
| 152 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.48179858 |
| 153 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.48179858 |
| 154 | positive regulation of ligase activity (GO:0051351) | 2.47634358 |
| 155 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.47237810 |
| 156 | serine transport (GO:0032329) | 2.46825682 |
| 157 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.46808853 |
| 158 | protein targeting to mitochondrion (GO:0006626) | 2.46333511 |
| 159 | regulation of ligase activity (GO:0051340) | 2.46316481 |
| 160 | DNA strand elongation (GO:0022616) | 2.45799019 |
| 161 | negative regulation of mitochondrion organization (GO:0010823) | 2.45170716 |
| 162 | de novo posttranslational protein folding (GO:0051084) | 2.45169247 |
| 163 | pseudouridine synthesis (GO:0001522) | 2.45073745 |
| 164 | * dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.45027777 |
| 165 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.43520262 |
| 166 | mitotic metaphase plate congression (GO:0007080) | 2.43201261 |
| 167 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.43030049 |
| 168 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.42981590 |
| 169 | monosaccharide biosynthetic process (GO:0046364) | 2.42189445 |
| 170 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.39939964 |
| 171 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.39912153 |
| 172 | L-methionine biosynthetic process (GO:0071265) | 2.39745613 |
| 173 | amino acid salvage (GO:0043102) | 2.39745613 |
| 174 | L-methionine salvage (GO:0071267) | 2.39745613 |
| 175 | cell adhesion mediated by integrin (GO:0033627) | 2.37089439 |
| 176 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.32246818 |
| 177 | rRNA transcription (GO:0009303) | 2.32101696 |
| 178 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.31811866 |
| 179 | nucleoside transmembrane transport (GO:1901642) | 2.30812270 |
| 180 | chaperone-mediated protein transport (GO:0072321) | 2.30635713 |
| 181 | protein complex localization (GO:0031503) | 2.30448646 |
| 182 | gluconeogenesis (GO:0006094) | 2.30382619 |
| 183 | glucose catabolic process (GO:0006007) | 2.29477988 |
| 184 | tetrahydrofolate metabolic process (GO:0046653) | 2.27816288 |
| 185 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.27502950 |
| 186 | termination of RNA polymerase III transcription (GO:0006386) | 2.27052649 |
| 187 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.27052649 |
| 188 | hexose biosynthetic process (GO:0019319) | 2.26529004 |
| 189 | ribosome assembly (GO:0042255) | 2.26302045 |
| 190 | glycine metabolic process (GO:0006544) | 2.26049965 |
| 191 | folic acid-containing compound metabolic process (GO:0006760) | 2.25865803 |
| 192 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.24225997 |
| 193 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.24198287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.69241603 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.15905181 |
| 3 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.74295828 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.80950673 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.59136722 |
| 6 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.44646037 |
| 7 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.19907633 |
| 8 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.96684460 |
| 9 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.90897943 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.83030311 |
| 11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.81474135 |
| 12 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.75187788 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.57917843 |
| 14 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.57598337 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.53505995 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.38244715 |
| 17 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.34948327 |
| 18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.33665856 |
| 19 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.32867851 |
| 20 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.31399204 |
| 21 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.27755702 |
| 22 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.23072553 |
| 23 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.22596507 |
| 24 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.16933697 |
| 25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.14144395 |
| 26 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.10276925 |
| 27 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 2.04636262 |
| 28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.01082739 |
| 29 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.97856623 |
| 30 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.96635132 |
| 31 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.96567852 |
| 32 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.94498871 |
| 33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.92556124 |
| 34 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.87457683 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.83213930 |
| 36 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.81398565 |
| 37 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.79260793 |
| 38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.78871263 |
| 39 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.75454478 |
| 40 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.75190179 |
| 41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.74960048 |
| 42 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.72511001 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.66533002 |
| 44 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.62709543 |
| 45 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.59005878 |
| 46 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.55943750 |
| 47 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.54710216 |
| 48 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.53876763 |
| 49 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.50547461 |
| 50 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.48830059 |
| 51 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.47936474 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.47141175 |
| 53 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.46594473 |
| 54 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.45041203 |
| 55 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.44983614 |
| 56 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.41732264 |
| 57 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.41678921 |
| 58 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.41167159 |
| 59 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.41153844 |
| 60 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.38141627 |
| 61 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.33804060 |
| 62 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.28742274 |
| 63 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.27495697 |
| 64 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.26747164 |
| 65 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.25663198 |
| 66 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.25014666 |
| 67 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.23677207 |
| 68 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.22946097 |
| 69 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.21837235 |
| 70 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.20276976 |
| 71 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.19617836 |
| 72 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.19540179 |
| 73 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18673390 |
| 74 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.18244747 |
| 75 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.17937850 |
| 76 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.17762033 |
| 77 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.16891288 |
| 78 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.16054333 |
| 79 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.15964485 |
| 80 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.15438650 |
| 81 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.14047271 |
| 82 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.13827510 |
| 83 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.13710332 |
| 84 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.11694227 |
| 85 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.11507451 |
| 86 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.10769853 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.10440938 |
| 88 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.09893022 |
| 89 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.09582990 |
| 90 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.09567698 |
| 91 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.07710156 |
| 92 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.07433047 |
| 93 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.06146266 |
| 94 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.04916490 |
| 95 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.03858496 |
| 96 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.03842192 |
| 97 | ATF3_27146783_Chip-Seq_COLON_Human | 1.02325972 |
| 98 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.01996644 |
| 99 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.01155804 |
| 100 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.00778729 |
| 101 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.00674113 |
| 102 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.00648010 |
| 103 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.00574400 |
| 104 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.99342864 |
| 105 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.99330524 |
| 106 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.96171450 |
| 107 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.96095155 |
| 108 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.95062504 |
| 109 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.94035336 |
| 110 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.93692440 |
| 111 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.93531324 |
| 112 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.93000228 |
| 113 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.92453428 |
| 114 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91935208 |
| 115 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.90547391 |
| 116 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.90394533 |
| 117 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.89207373 |
| 118 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88995230 |
| 119 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.87545033 |
| 120 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.86117775 |
| 121 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.85848086 |
| 122 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.85302616 |
| 123 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.84668825 |
| 124 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.82716092 |
| 125 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.82669664 |
| 126 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.82669664 |
| 127 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82163287 |
| 128 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.81221335 |
| 129 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.80957303 |
| 130 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.79483973 |
| 131 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.79381067 |
| 132 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.78218259 |
| 133 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.77543977 |
| 134 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.77202260 |
| 135 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.76667175 |
| 136 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.76130940 |
| 137 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.74161855 |
| 138 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73806529 |
| 139 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.73539615 |
| 140 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73376249 |
| 141 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.71820117 |
| 142 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.71429994 |
| 143 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.71351265 |
| 144 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.70813938 |
| 145 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.69289104 |
| 146 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.68283155 |
| 147 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.68198032 |
| 148 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.67812599 |
| 149 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.67734245 |
| 150 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.66827711 |
| 151 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.66469390 |
| 152 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.65358206 |
| 153 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.65120600 |
| 154 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.64529960 |
| 155 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.64493286 |
| 156 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.64295339 |
| 157 | PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.63980437 |
| 158 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.63838154 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.79308798 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.41370650 |
| 3 | MP0005670_abnormal_white_adipose | 3.74145132 |
| 4 | MP0004130_abnormal_muscle_cell | 3.46541358 |
| 5 | MP0000013_abnormal_adipose_tissue | 3.18295265 |
| 6 | MP0003195_calcinosis | 3.12528259 |
| 7 | MP0005257_abnormal_intraocular_pressure | 3.00918938 |
| 8 | MP0002139_abnormal_hepatobiliary_system | 3.00436644 |
| 9 | MP0003941_abnormal_skin_development | 2.96860060 |
| 10 | MP0003806_abnormal_nucleotide_metabolis | 2.91215750 |
| 11 | MP0005365_abnormal_bile_salt | 2.84753845 |
| 12 | MP0000003_abnormal_adipose_tissue | 2.71021863 |
| 13 | MP0005666_abnormal_adipose_tissue | 2.59768322 |
| 14 | MP0005275_abnormal_skin_tensile | 2.53476876 |
| 15 | MP0010030_abnormal_orbit_morphology | 2.52444482 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.48161476 |
| 17 | MP0008789_abnormal_olfactory_epithelium | 2.47979694 |
| 18 | MP0005375_adipose_tissue_phenotype | 2.44631436 |
| 19 | MP0003693_abnormal_embryo_hatching | 2.36524931 |
| 20 | MP0004233_abnormal_muscle_weight | 2.32001826 |
| 21 | MP0005360_urolithiasis | 2.26502909 |
| 22 | MP0008932_abnormal_embryonic_tissue | 2.24005769 |
| 23 | MP0004957_abnormal_blastocyst_morpholog | 2.16957966 |
| 24 | MP0005623_abnormal_meninges_morphology | 2.09000768 |
| 25 | MP0003111_abnormal_nucleus_morphology | 2.05241844 |
| 26 | MP0004185_abnormal_adipocyte_glucose | 2.04804962 |
| 27 | MP0005499_abnormal_olfactory_system | 2.04194854 |
| 28 | MP0005394_taste/olfaction_phenotype | 2.04194854 |
| 29 | MP0000751_myopathy | 1.98133245 |
| 30 | MP0002118_abnormal_lipid_homeostasis | 1.95748909 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.94123221 |
| 32 | MP0006036_abnormal_mitochondrial_physio | 1.90502207 |
| 33 | MP0009840_abnormal_foam_cell | 1.90210384 |
| 34 | MP0002971_abnormal_brown_adipose | 1.79561790 |
| 35 | MP0005503_abnormal_tendon_morphology | 1.76803425 |
| 36 | MP0003566_abnormal_cell_adhesion | 1.73986440 |
| 37 | MP0005332_abnormal_amino_acid | 1.68417818 |
| 38 | MP0000749_muscle_degeneration | 1.66725963 |
| 39 | MP0010352_gastrointestinal_tract_polyps | 1.66487682 |
| 40 | MP0002876_abnormal_thyroid_physiology | 1.65704713 |
| 41 | MP0004147_increased_porphyrin_level | 1.65197177 |
| 42 | MP0001661_extended_life_span | 1.62351889 |
| 43 | MP0000537_abnormal_urethra_morphology | 1.61927018 |
| 44 | MP0003329_amyloid_beta_deposits | 1.61075374 |
| 45 | MP0009053_abnormal_anal_canal | 1.60009503 |
| 46 | MP0008260_abnormal_autophagy | 1.59935358 |
| 47 | MP0003077_abnormal_cell_cycle | 1.57965114 |
| 48 | MP0005501_abnormal_skin_physiology | 1.57836785 |
| 49 | MP0000747_muscle_weakness | 1.53624332 |
| 50 | MP0010094_abnormal_chromosome_stability | 1.51993705 |
| 51 | MP0009697_abnormal_copulation | 1.50347792 |
| 52 | MP0002060_abnormal_skin_morphology | 1.49912202 |
| 53 | MP0004215_abnormal_myocardial_fiber | 1.47532601 |
| 54 | MP0001730_embryonic_growth_arrest | 1.47332248 |
| 55 | MP0005085_abnormal_gallbladder_physiolo | 1.46218217 |
| 56 | MP0002877_abnormal_melanocyte_morpholog | 1.46195813 |
| 57 | MP0004036_abnormal_muscle_relaxation | 1.42970324 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 1.41452698 |
| 59 | MP0005535_abnormal_body_temperature | 1.41282679 |
| 60 | MP0001849_ear_inflammation | 1.40164862 |
| 61 | MP0005451_abnormal_body_composition | 1.39686250 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.38662029 |
| 63 | MP0002638_abnormal_pupillary_reflex | 1.35747559 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 1.34759788 |
| 65 | MP0005334_abnormal_fat_pad | 1.34671369 |
| 66 | MP0001727_abnormal_embryo_implantation | 1.33163184 |
| 67 | MP0002078_abnormal_glucose_homeostasis | 1.32849490 |
| 68 | MP0003646_muscle_fatigue | 1.31976840 |
| 69 | MP0002796_impaired_skin_barrier | 1.31740055 |
| 70 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.30464101 |
| 71 | MP0003718_maternal_effect | 1.30384246 |
| 72 | MP0002970_abnormal_white_adipose | 1.27264984 |
| 73 | MP0003705_abnormal_hypodermis_morpholog | 1.26924898 |
| 74 | MP0010368_abnormal_lymphatic_system | 1.26742373 |
| 75 | MP0008007_abnormal_cellular_replicative | 1.24868127 |
| 76 | MP0003786_premature_aging | 1.22330758 |
| 77 | MP0005448_abnormal_energy_balance | 1.21353657 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 1.20767895 |
| 79 | MP0005319_abnormal_enzyme/_coenzyme | 1.20192256 |
| 80 | MP0005330_cardiomyopathy | 1.20186417 |
| 81 | MP0003315_abnormal_perineum_morphology | 1.19984660 |
| 82 | MP0000609_abnormal_liver_physiology | 1.19981730 |
| 83 | MP0000750_abnormal_muscle_regeneration | 1.19678820 |
| 84 | MP0002697_abnormal_eye_size | 1.19669594 |
| 85 | MP0008058_abnormal_DNA_repair | 1.19380290 |
| 86 | MP0004272_abnormal_basement_membrane | 1.18655627 |
| 87 | MP0002233_abnormal_nose_morphology | 1.17908517 |
| 88 | MP0003942_abnormal_urinary_system | 1.16831484 |
| 89 | MP0009115_abnormal_fat_cell | 1.16256538 |
| 90 | MP0001243_abnormal_dermal_layer | 1.15706845 |
| 91 | MP0002269_muscular_atrophy | 1.15383627 |
| 92 | MP0003186_abnormal_redox_activity | 1.15265505 |
| 93 | MP0005367_renal/urinary_system_phenotyp | 1.15105410 |
| 94 | MP0000516_abnormal_urinary_system | 1.15105410 |
| 95 | MP0001542_abnormal_bone_strength | 1.14660969 |
| 96 | MP0001764_abnormal_homeostasis | 1.13156495 |
| 97 | MP0004084_abnormal_cardiac_muscle | 1.13041761 |
| 98 | MP0009672_abnormal_birth_weight | 1.11138215 |
| 99 | MP0000762_abnormal_tongue_morphology | 1.10481991 |
| 100 | MP0002090_abnormal_vision | 1.09777342 |
| 101 | MP0003252_abnormal_bile_duct | 1.08483974 |
| 102 | MP0000049_abnormal_middle_ear | 1.07444705 |
| 103 | MP0002108_abnormal_muscle_morphology | 1.06000811 |
| 104 | MP0000759_abnormal_skeletal_muscle | 1.04247050 |
| 105 | MP0003959_abnormal_lean_body | 1.03500239 |
| 106 | MP0005197_abnormal_uvea_morphology | 1.03009546 |
| 107 | MP0003385_abnormal_body_wall | 1.02813247 |
| 108 | MP0002080_prenatal_lethality | 1.02691369 |
| 109 | MP0005380_embryogenesis_phenotype | 1.01077694 |
| 110 | MP0001672_abnormal_embryogenesis/_devel | 1.01077694 |
| 111 | MP0002909_abnormal_adrenal_gland | 1.00153665 |
| 112 | MP0003279_aneurysm | 0.99922067 |
| 113 | MP0001529_abnormal_vocalization | 0.99701502 |
| 114 | MP0005452_abnormal_adipose_tissue | 0.98312167 |
| 115 | MP0008775_abnormal_heart_ventricle | 0.97658983 |
| 116 | MP0003937_abnormal_limbs/digits/tail_de | 0.97616961 |
| 117 | MP0006138_congestive_heart_failure | 0.97259439 |
| 118 | MP0000579_abnormal_nail_morphology | 0.97052146 |
| 119 | MP0002092_abnormal_eye_morphology | 0.96713071 |
| 120 | MP0000678_abnormal_parathyroid_gland | 0.95914150 |
| 121 | MP0005508_abnormal_skeleton_morphology | 0.95521207 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.95420893 |
| 123 | MP0002085_abnormal_embryonic_tissue | 0.95040216 |
| 124 | MP0000604_amyloidosis | 0.94757760 |
| 125 | MP0002254_reproductive_system_inflammat | 0.93009974 |
| 126 | MP0001915_intracranial_hemorrhage | 0.91890168 |
| 127 | MP0000350_abnormal_cell_proliferation | 0.91460324 |
| 128 | MP0008875_abnormal_xenobiotic_pharmacok | 0.90860922 |
| 129 | MP0009250_abnormal_appendicular_skeleto | 0.90789408 |
| 130 | MP0003984_embryonic_growth_retardation | 0.90551062 |
| 131 | MP0003755_abnormal_palate_morphology | 0.90535902 |
| 132 | MP0005620_abnormal_muscle_contractility | 0.90140125 |
| 133 | MP0003953_abnormal_hormone_level | 0.89015219 |
| 134 | MP0003690_abnormal_glial_cell | 0.88637688 |
| 135 | MP0010771_integument_phenotype | 0.88623925 |
| 136 | MP0004858_abnormal_nervous_system | 0.86722450 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.86632067 |
| 138 | MP0001697_abnormal_embryo_size | 0.85746327 |
| 139 | MP0002111_abnormal_tail_morphology | 0.85383687 |
| 140 | MP0005408_hypopigmentation | 0.84159325 |
| 141 | MP0000467_abnormal_esophagus_morphology | 0.82862278 |
| 142 | MP0000462_abnormal_digestive_system | 0.82850570 |
| 143 | MP0001544_abnormal_cardiovascular_syste | 0.82635826 |
| 144 | MP0005385_cardiovascular_system_phenoty | 0.82635826 |
| 145 | MP0003011_delayed_dark_adaptation | 0.82252586 |
| 146 | MP0001216_abnormal_epidermal_layer | 0.81346738 |
| 147 | MP0005193_abnormal_anterior_eye | 0.80764779 |
| 148 | MP0003123_paternal_imprinting | 0.80533975 |
| 149 | MP0000534_abnormal_ureter_morphology | 0.80262189 |
| 150 | MP0005084_abnormal_gallbladder_morpholo | 0.80244854 |
| 151 | MP0002088_abnormal_embryonic_growth/wei | 0.80053461 |
| 152 | MP0001666_abnormal_nutrient_absorption | 0.79845020 |
| 153 | MP0006054_spinal_hemorrhage | 0.79496172 |
| 154 | MP0004019_abnormal_vitamin_homeostasis | 0.78889463 |
| 155 | MP0005636_abnormal_mineral_homeostasis | 0.77775985 |
| 156 | MP0002084_abnormal_developmental_patter | 0.77447777 |
| 157 | MP0005369_muscle_phenotype | 0.77375996 |
| 158 | MP0006276_abnormal_autonomic_nervous | 0.77338287 |
| 159 | MP0005220_abnormal_exocrine_pancreas | 0.76845439 |
| 160 | MP0005384_cellular_phenotype | 0.76844264 |
| 161 | MP0009643_abnormal_urine_homeostasis | 0.76551198 |
| 162 | MP0001881_abnormal_mammary_gland | 0.76183690 |
| 163 | MP0004043_abnormal_pH_regulation | 0.74413553 |
| 164 | MP0002736_abnormal_nociception_after | 0.72971674 |
| 165 | MP0008961_abnormal_basal_metabolism | 0.72696263 |
| 166 | MP0004145_abnormal_muscle_electrophysio | 0.72318569 |
| 167 | MP0009384_cardiac_valve_regurgitation | 0.71203526 |
| 168 | MP0005083_abnormal_biliary_tract | 0.69154241 |
| 169 | MP0003137_abnormal_impulse_conducting | 0.68964163 |
| 170 | MP0004087_abnormal_muscle_fiber | 0.68668096 |
| 171 | MP0001984_abnormal_olfaction | 0.68114122 |
| 172 | MP0001299_abnormal_eye_distance/ | 0.65645344 |
| 173 | MP0000358_abnormal_cell_content/ | 0.65572217 |
| 174 | MP0002972_abnormal_cardiac_muscle | 0.64994147 |
| 175 | MP0004270_analgesia | 0.63944418 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hepatic necrosis (HP:0002605) | 3.98227469 |
| 2 | Oligomenorrhea (HP:0000876) | 3.89989182 |
| 3 | Hypoglycemic coma (HP:0001325) | 3.68502036 |
| 4 | Hyperglycinuria (HP:0003108) | 3.63562123 |
| 5 | Hepatocellular necrosis (HP:0001404) | 3.62622858 |
| 6 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.47902986 |
| 7 | Hyperlipoproteinemia (HP:0010980) | 3.44234370 |
| 8 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.37541519 |
| 9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.37130239 |
| 10 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.36772413 |
| 11 | Abnormality of glycine metabolism (HP:0010895) | 3.36772413 |
| 12 | Short nail (HP:0001799) | 3.30586605 |
| 13 | Acute encephalopathy (HP:0006846) | 3.25963265 |
| 14 | Acute necrotizing encephalopathy (HP:0006965) | 3.21605880 |
| 15 | Myoglobinuria (HP:0002913) | 3.19156842 |
| 16 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.19040058 |
| 17 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.19040058 |
| 18 | Ketosis (HP:0001946) | 3.18954548 |
| 19 | Ketoacidosis (HP:0001993) | 3.17696724 |
| 20 | Hyperammonemia (HP:0001987) | 3.00113361 |
| 21 | Cerebral edema (HP:0002181) | 2.99061394 |
| 22 | Hyperglycinemia (HP:0002154) | 2.99058156 |
| 23 | Mitochondrial inheritance (HP:0001427) | 2.91305132 |
| 24 | Lactic acidosis (HP:0003128) | 2.90462155 |
| 25 | Pheochromocytoma (HP:0002666) | 2.88552249 |
| 26 | Xanthomatosis (HP:0000991) | 2.88217023 |
| 27 | Dicarboxylic aciduria (HP:0003215) | 2.87231178 |
| 28 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.87231178 |
| 29 | Abnormality of glycolysis (HP:0004366) | 2.86370188 |
| 30 | Increased serum pyruvate (HP:0003542) | 2.86370188 |
| 31 | Abnormality of glycolipid metabolism (HP:0010969) | 2.81509383 |
| 32 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.81509383 |
| 33 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.81509383 |
| 34 | Neuroendocrine neoplasm (HP:0100634) | 2.74421566 |
| 35 | Microretrognathia (HP:0000308) | 2.73924934 |
| 36 | Brushfield spots (HP:0001088) | 2.72880308 |
| 37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.72374668 |
| 38 | Progressive macrocephaly (HP:0004481) | 2.72090661 |
| 39 | Reduced antithrombin III activity (HP:0001976) | 2.66547923 |
| 40 | Increased CSF lactate (HP:0002490) | 2.66443928 |
| 41 | Ragged-red muscle fibers (HP:0003200) | 2.59516950 |
| 42 | Increased muscle lipid content (HP:0009058) | 2.58836883 |
| 43 | Myocardial infarction (HP:0001658) | 2.58017581 |
| 44 | Protrusio acetabuli (HP:0003179) | 2.55702034 |
| 45 | Epiphyseal stippling (HP:0010655) | 2.54883568 |
| 46 | Intrahepatic cholestasis (HP:0001406) | 2.49497776 |
| 47 | Type I transferrin isoform profile (HP:0003642) | 2.47992306 |
| 48 | Cholecystitis (HP:0001082) | 2.46367679 |
| 49 | Abnormal gallbladder physiology (HP:0012438) | 2.46367679 |
| 50 | Abnormality of dentin (HP:0010299) | 2.45273816 |
| 51 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.45263760 |
| 52 | Abnormality of alanine metabolism (HP:0010916) | 2.45263760 |
| 53 | Hyperalaninemia (HP:0003348) | 2.45263760 |
| 54 | Premature rupture of membranes (HP:0001788) | 2.44937261 |
| 55 | Hydroureter (HP:0000072) | 2.44687541 |
| 56 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.40720100 |
| 57 | Rhabdomyolysis (HP:0003201) | 2.39665614 |
| 58 | * Abnormal protein glycosylation (HP:0012346) | 2.39541107 |
| 59 | * Abnormal glycosylation (HP:0012345) | 2.39541107 |
| 60 | * Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.39541107 |
| 61 | * Abnormal protein N-linked glycosylation (HP:0012347) | 2.39541107 |
| 62 | Lethargy (HP:0001254) | 2.39410253 |
| 63 | Methylmalonic aciduria (HP:0012120) | 2.36208187 |
| 64 | Rough bone trabeculation (HP:0100670) | 2.35202243 |
| 65 | Ankle contracture (HP:0006466) | 2.33139048 |
| 66 | Prolonged neonatal jaundice (HP:0006579) | 2.32636978 |
| 67 | Hand muscle atrophy (HP:0009130) | 2.32174042 |
| 68 | Hypokinesia (HP:0002375) | 2.31477718 |
| 69 | Microvesicular hepatic steatosis (HP:0001414) | 2.27939880 |
| 70 | Respiratory failure (HP:0002878) | 2.27460557 |
| 71 | Progressive muscle weakness (HP:0003323) | 2.25838091 |
| 72 | Acanthosis nigricans (HP:0000956) | 2.24399958 |
| 73 | Upper limb muscle weakness (HP:0003484) | 2.22364463 |
| 74 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.20862067 |
| 75 | Abnormality of the intrinsic pathway (HP:0010989) | 2.20335554 |
| 76 | Upper limb amyotrophy (HP:0009129) | 2.19373476 |
| 77 | Distal upper limb amyotrophy (HP:0007149) | 2.19373476 |
| 78 | Cortical dysplasia (HP:0002539) | 2.19159874 |
| 79 | Hypoglycemic seizures (HP:0002173) | 2.18433198 |
| 80 | Difficulty running (HP:0009046) | 2.16150288 |
| 81 | Generalized aminoaciduria (HP:0002909) | 2.15043323 |
| 82 | CNS demyelination (HP:0007305) | 2.13620058 |
| 83 | Hypoalphalipoproteinemia (HP:0003233) | 2.11860337 |
| 84 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.11547148 |
| 85 | Testicular atrophy (HP:0000029) | 2.10875951 |
| 86 | Nausea (HP:0002018) | 2.10736999 |
| 87 | Palpitations (HP:0001962) | 2.10509389 |
| 88 | Trismus (HP:0000211) | 2.08496840 |
| 89 | Calf muscle hypertrophy (HP:0008981) | 2.07692987 |
| 90 | Vomiting (HP:0002013) | 2.07511127 |
| 91 | Myotonia (HP:0002486) | 2.06941059 |
| 92 | Complement deficiency (HP:0004431) | 2.06809523 |
| 93 | Abnormality of serum amino acid levels (HP:0003112) | 2.06427560 |
| 94 | Achilles tendon contracture (HP:0001771) | 2.06427513 |
| 95 | Biconcave vertebral bodies (HP:0004586) | 2.06326517 |
| 96 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.05286301 |
| 97 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.05102287 |
| 98 | Gout (HP:0001997) | 2.04395214 |
| 99 | Increased serum lactate (HP:0002151) | 2.04379202 |
| 100 | Spinal rigidity (HP:0003306) | 2.03234644 |
| 101 | Abnormality of the umbilical cord (HP:0010881) | 2.02897190 |
| 102 | Multiple enchondromatosis (HP:0005701) | 2.02615523 |
| 103 | Poor head control (HP:0002421) | 2.01586839 |
| 104 | Septate vagina (HP:0001153) | 2.01034360 |
| 105 | Vertebral compression fractures (HP:0002953) | 2.00205415 |
| 106 | Hypertriglyceridemia (HP:0002155) | 1.99951777 |
| 107 | Abnormal cartilage morphology (HP:0002763) | 1.98857362 |
| 108 | Atrophic scars (HP:0001075) | 1.97436991 |
| 109 | Selective tooth agenesis (HP:0001592) | 1.97419305 |
| 110 | Abnormality of carpal bone ossification (HP:0006257) | 1.94461749 |
| 111 | Cervical subluxation (HP:0003308) | 1.93002042 |
| 112 | Vaginal fistula (HP:0004320) | 1.92891257 |
| 113 | Abnormality of proline metabolism (HP:0010907) | 1.92512345 |
| 114 | Hydroxyprolinuria (HP:0003080) | 1.92512345 |
| 115 | Muscle stiffness (HP:0003552) | 1.91958408 |
| 116 | Exercise intolerance (HP:0003546) | 1.91922684 |
| 117 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.91617843 |
| 118 | Vacuolated lymphocytes (HP:0001922) | 1.90387512 |
| 119 | Hypolipoproteinemia (HP:0010981) | 1.89633778 |
| 120 | Muscle fiber splitting (HP:0003555) | 1.88123428 |
| 121 | Epidermoid cyst (HP:0200040) | 1.87304218 |
| 122 | Poor suck (HP:0002033) | 1.87164199 |
| 123 | Hypoplastic left heart (HP:0004383) | 1.86753049 |
| 124 | Sparse lateral eyebrow (HP:0005338) | 1.85876185 |
| 125 | Exercise-induced myalgia (HP:0003738) | 1.85447808 |
| 126 | Insulin resistance (HP:0000855) | 1.85253961 |
| 127 | Broad distal phalanx of finger (HP:0009836) | 1.85158365 |
| 128 | Abnormal trabecular bone morphology (HP:0100671) | 1.85055962 |
| 129 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.84188042 |
| 130 | Hyperglycemia (HP:0003074) | 1.83722661 |
| 131 | Deep venous thrombosis (HP:0002625) | 1.83169813 |
| 132 | Abnormality of the Achilles tendon (HP:0005109) | 1.82736963 |
| 133 | Colon cancer (HP:0003003) | 1.82303753 |
| 134 | Conjunctival hamartoma (HP:0100780) | 1.80700998 |
| 135 | Metabolic acidosis (HP:0001942) | 1.79675518 |
| 136 | Type II lissencephaly (HP:0007260) | 1.78864905 |
| 137 | Congenital glaucoma (HP:0001087) | 1.78313945 |
| 138 | Abnormal epiphyseal ossification (HP:0010656) | 1.77475535 |
| 139 | Late onset (HP:0003584) | 1.76597229 |
| 140 | Ulnar bowing (HP:0003031) | 1.75748536 |
| 141 | Emotional lability (HP:0000712) | 1.74887021 |
| 142 | Cerebral hemorrhage (HP:0001342) | 1.74260896 |
| 143 | Generalized amyotrophy (HP:0003700) | 1.73892479 |
| 144 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.72839771 |
| 145 | Increased intramyocellular lipid droplets (HP:0012240) | 1.72464395 |
| 146 | Spastic diplegia (HP:0001264) | 1.72194748 |
| 147 | Impaired pain sensation (HP:0007328) | 1.70986557 |
| 148 | Abnormality of pain sensation (HP:0010832) | 1.70986557 |
| 149 | Symptomatic seizures (HP:0011145) | 1.70898127 |
| 150 | Asymmetric septal hypertrophy (HP:0001670) | 1.70573839 |
| 151 | Abnormality of the phalanges of the hallux (HP:0010057) | 1.69880048 |
| 152 | Redundant skin (HP:0001582) | 1.69848724 |
| 153 | Generalized hypotonia (HP:0001290) | 1.69735838 |
| 154 | Microglossia (HP:0000171) | 1.69055381 |
| 155 | Retinal dysplasia (HP:0007973) | 1.68925437 |
| 156 | Methylmalonic acidemia (HP:0002912) | 1.67970871 |
| 157 | Acute hepatic failure (HP:0006554) | 1.66438641 |
| 158 | Secondary amenorrhea (HP:0000869) | 1.66203678 |
| 159 | Opisthotonus (HP:0002179) | 1.65710376 |
| 160 | Breech presentation (HP:0001623) | 1.65479771 |
| 161 | Entropion (HP:0000621) | 1.63521953 |
| 162 | Elbow flexion contracture (HP:0002987) | 1.60943157 |
| 163 | Hypoplastic pelvis (HP:0008839) | 1.60247942 |
| 164 | Facial cleft (HP:0002006) | 1.59571161 |
| 165 | Long toe (HP:0010511) | 1.58506825 |
| 166 | Abnormal delivery (HP:0001787) | 1.57733215 |
| 167 | Fasciculations (HP:0002380) | 1.55780664 |
| 168 | Long palpebral fissure (HP:0000637) | 1.55408628 |
| 169 | Abnormal gallbladder morphology (HP:0012437) | 1.54980584 |
| 170 | Abnormality of the gallbladder (HP:0005264) | 1.53481932 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 5.69497026 |
| 2 | TRIB3 | 4.06077087 |
| 3 | VRK2 | 3.63032663 |
| 4 | PBK | 3.36656112 |
| 5 | SMG1 | 3.18016735 |
| 6 | TESK1 | 3.16599628 |
| 7 | PHKG2 | 3.06458703 |
| 8 | PHKG1 | 3.06458703 |
| 9 | EPHA2 | 2.60000867 |
| 10 | SIK1 | 2.46041246 |
| 11 | LMTK2 | 2.38767826 |
| 12 | IRAK3 | 2.25343639 |
| 13 | PDK4 | 2.17199399 |
| 14 | PDK3 | 2.17199399 |
| 15 | MYLK | 2.15061174 |
| 16 | CASK | 2.06644641 |
| 17 | PAK4 | 1.95096701 |
| 18 | TAF1 | 1.94854129 |
| 19 | ERN1 | 1.92735510 |
| 20 | NEK1 | 1.84986245 |
| 21 | INSRR | 1.82794650 |
| 22 | TTK | 1.79100889 |
| 23 | AKT3 | 1.68237884 |
| 24 | TTN | 1.60155434 |
| 25 | BRSK1 | 1.59251721 |
| 26 | CAMK1D | 1.58851378 |
| 27 | FER | 1.57150217 |
| 28 | ABL2 | 1.51739290 |
| 29 | MUSK | 1.50247368 |
| 30 | LATS2 | 1.44390774 |
| 31 | TNK2 | 1.42902958 |
| 32 | AURKA | 1.38955149 |
| 33 | PDK2 | 1.38939966 |
| 34 | LIMK1 | 1.34574001 |
| 35 | ARAF | 1.33947198 |
| 36 | MET | 1.29698755 |
| 37 | TRIM28 | 1.28988260 |
| 38 | TSSK6 | 1.27587366 |
| 39 | CSNK1A1L | 1.26145224 |
| 40 | SRPK1 | 1.25981338 |
| 41 | ICK | 1.23978755 |
| 42 | PINK1 | 1.23463088 |
| 43 | NME2 | 1.22676310 |
| 44 | CDC7 | 1.17174313 |
| 45 | CAMKK2 | 1.16410347 |
| 46 | MAP2K4 | 1.15999633 |
| 47 | SCYL2 | 1.14362934 |
| 48 | STK16 | 1.10906175 |
| 49 | CAMK2G | 1.10120308 |
| 50 | CSNK1G1 | 1.09143497 |
| 51 | SGK223 | 1.08652707 |
| 52 | SGK494 | 1.08652707 |
| 53 | EIF2AK1 | 1.07851763 |
| 54 | PLK1 | 1.05523058 |
| 55 | MAP2K1 | 1.04888824 |
| 56 | PRKD3 | 1.04034424 |
| 57 | DAPK1 | 1.03603975 |
| 58 | BRAF | 1.02009418 |
| 59 | MINK1 | 1.01732968 |
| 60 | CDK7 | 1.01447796 |
| 61 | NTRK1 | 0.98022922 |
| 62 | MAP2K7 | 0.96545284 |
| 63 | DDR2 | 0.94314549 |
| 64 | FRK | 0.93475507 |
| 65 | BUB1 | 0.93196171 |
| 66 | PAK3 | 0.91881921 |
| 67 | TAOK2 | 0.89047206 |
| 68 | MAP3K4 | 0.88709284 |
| 69 | CAMK2D | 0.87131655 |
| 70 | MAP3K3 | 0.85300311 |
| 71 | AURKB | 0.83958226 |
| 72 | PLK3 | 0.83534152 |
| 73 | EPHA4 | 0.82702552 |
| 74 | PIK3CG | 0.82659464 |
| 75 | MAPKAPK5 | 0.81912055 |
| 76 | PIK3CA | 0.81881588 |
| 77 | PRKCI | 0.80436401 |
| 78 | GRK5 | 0.80316239 |
| 79 | MAP3K8 | 0.78913281 |
| 80 | TESK2 | 0.77876251 |
| 81 | STK38L | 0.76815409 |
| 82 | RPS6KA4 | 0.76564813 |
| 83 | CDK9 | 0.76381010 |
| 84 | PRKAA2 | 0.75859819 |
| 85 | CHEK2 | 0.75368639 |
| 86 | ILK | 0.74905116 |
| 87 | PDPK1 | 0.73833578 |
| 88 | MAP3K5 | 0.71804737 |
| 89 | DYRK2 | 0.71754118 |
| 90 | EPHB2 | 0.71393785 |
| 91 | MAPK12 | 0.71354868 |
| 92 | MAP3K6 | 0.70905457 |
| 93 | MST1R | 0.70669262 |
| 94 | PIM2 | 0.70002202 |
| 95 | TIE1 | 0.69752332 |
| 96 | ERBB4 | 0.69157506 |
| 97 | DAPK3 | 0.67996683 |
| 98 | MELK | 0.67471858 |
| 99 | PRKCE | 0.67233756 |
| 100 | CAMK1G | 0.66586295 |
| 101 | PRKCG | 0.66436892 |
| 102 | OBSCN | 0.65215115 |
| 103 | NTRK3 | 0.65141039 |
| 104 | CAMK2B | 0.62507467 |
| 105 | MAP3K11 | 0.60251733 |
| 106 | PTK2B | 0.59911217 |
| 107 | PDGFRA | 0.59911009 |
| 108 | VRK1 | 0.59347130 |
| 109 | PRKACG | 0.59103160 |
| 110 | WEE1 | 0.58855833 |
| 111 | MAP3K9 | 0.58373069 |
| 112 | CDK8 | 0.58117240 |
| 113 | MAP2K3 | 0.57558569 |
| 114 | DYRK3 | 0.57190172 |
| 115 | MAPK4 | 0.56755629 |
| 116 | AKT2 | 0.56401684 |
| 117 | EPHB1 | 0.53543135 |
| 118 | LATS1 | 0.52998522 |
| 119 | CHEK1 | 0.52934278 |
| 120 | KDR | 0.50895186 |
| 121 | PTK2 | 0.50827829 |
| 122 | CAMK2A | 0.50762664 |
| 123 | MAPK11 | 0.50413713 |
| 124 | SGK2 | 0.49876102 |
| 125 | MAP3K12 | 0.49402574 |
| 126 | PAK2 | 0.49308673 |
| 127 | CDK14 | 0.49243043 |
| 128 | PAK6 | 0.49197772 |
| 129 | PRKACA | 0.49169775 |
| 130 | ACVR1B | 0.47981344 |
| 131 | STK10 | 0.47950180 |
| 132 | PRKD1 | 0.46586298 |
| 133 | CLK1 | 0.46548168 |
| 134 | PRKAA1 | 0.44736086 |
| 135 | RIPK1 | 0.43601678 |
| 136 | PRKCZ | 0.43545572 |
| 137 | CSNK1G3 | 0.43385158 |
| 138 | EIF2AK3 | 0.43245688 |
| 139 | NME1 | 0.42876495 |
| 140 | PAK1 | 0.42643811 |
| 141 | CSNK1G2 | 0.41703377 |
| 142 | CDK5 | 0.39957378 |
| 143 | ROCK2 | 0.39081551 |
| 144 | CDK18 | 0.38648813 |
| 145 | CCNB1 | 0.38425103 |
| 146 | CDK15 | 0.38419848 |
| 147 | KSR1 | 0.37772167 |
| 148 | BMX | 0.37366707 |
| 149 | TAOK1 | 0.36564563 |
| 150 | CDK11A | 0.35721293 |
| 151 | DYRK1B | 0.35647754 |
| 152 | CSNK2A1 | 0.34613154 |
| 153 | FLT3 | 0.33569460 |
| 154 | GSK3A | 0.29444629 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.15285036 |
| 2 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.49382746 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.15544645 |
| 4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.88198911 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.83713099 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.69020867 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65977304 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58608336 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.51353959 |
| 10 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.43452667 |
| 11 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.29601866 |
| 12 | DNA replication_Homo sapiens_hsa03030 | 2.22405738 |
| 13 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.13803804 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.09822984 |
| 15 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.07914311 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 2.07728230 |
| 17 | Peroxisome_Homo sapiens_hsa04146 | 2.02091238 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02091042 |
| 19 | Base excision repair_Homo sapiens_hsa03410 | 1.89812151 |
| 20 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.89678698 |
| 21 | Parkinsons disease_Homo sapiens_hsa05012 | 1.85478277 |
| 22 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.76515716 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.73261102 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.72732609 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.67640324 |
| 26 | Mismatch repair_Homo sapiens_hsa03430 | 1.57073303 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.54976258 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.50855305 |
| 29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.50035139 |
| 30 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.49523043 |
| 31 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.49324583 |
| 32 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.48893365 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48372405 |
| 34 | RNA polymerase_Homo sapiens_hsa03020 | 1.48301471 |
| 35 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.48001307 |
| 36 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.47616392 |
| 37 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.47329046 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.44980214 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.40318536 |
| 40 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.37984644 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.35148872 |
| 42 | Alzheimers disease_Homo sapiens_hsa05010 | 1.34198378 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.33079182 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31401163 |
| 45 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.30275323 |
| 46 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.29943137 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.23933280 |
| 48 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23268599 |
| 49 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.17609691 |
| 50 | Sulfur relay system_Homo sapiens_hsa04122 | 1.14204703 |
| 51 | Huntingtons disease_Homo sapiens_hsa05016 | 1.07479776 |
| 52 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.04008092 |
| 53 | Protein export_Homo sapiens_hsa03060 | 0.99673558 |
| 54 | Cell cycle_Homo sapiens_hsa04110 | 0.97905289 |
| 55 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.94064075 |
| 56 | RNA transport_Homo sapiens_hsa03013 | 0.93422159 |
| 57 | Proteasome_Homo sapiens_hsa03050 | 0.92057273 |
| 58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88354664 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.88337865 |
| 60 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.87984549 |
| 61 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.87128529 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86318444 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.82787315 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.82468828 |
| 65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81777842 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.79783499 |
| 67 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.78567535 |
| 68 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.77904677 |
| 69 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77575096 |
| 70 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.76732396 |
| 71 | Spliceosome_Homo sapiens_hsa03040 | 0.76604006 |
| 72 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.76167419 |
| 73 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.76144506 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.73329094 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.72279961 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.72019636 |
| 77 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71913618 |
| 78 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.70259617 |
| 79 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69233203 |
| 80 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.68326486 |
| 81 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.68288261 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65479727 |
| 83 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.65274379 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.64848542 |
| 85 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62965976 |
| 86 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.62838636 |
| 87 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.62226095 |
| 88 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.61621828 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.61440759 |
| 90 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.60500235 |
| 91 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60493424 |
| 92 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.60476448 |
| 93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.60351897 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.59326003 |
| 95 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.59051962 |
| 96 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.58678515 |
| 97 | Homologous recombination_Homo sapiens_hsa03440 | 0.56615281 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56167928 |
| 99 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.55322264 |
| 100 | Ribosome_Homo sapiens_hsa03010 | 0.53921383 |
| 101 | Histidine metabolism_Homo sapiens_hsa00340 | 0.50974327 |
| 102 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49930965 |
| 103 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47186199 |
| 104 | Basal transcription factors_Homo sapiens_hsa03022 | 0.47116880 |
| 105 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45693732 |
| 106 | Galactose metabolism_Homo sapiens_hsa00052 | 0.45390146 |
| 107 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.45045816 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.44499237 |
| 109 | Purine metabolism_Homo sapiens_hsa00230 | 0.44418344 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43569334 |
| 111 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43290240 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42320135 |
| 113 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.40427389 |
| 114 | ABC transporters_Homo sapiens_hsa02010 | 0.39920646 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.39496416 |
| 116 | Shigellosis_Homo sapiens_hsa05131 | 0.39258912 |
| 117 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39031646 |
| 118 | Bile secretion_Homo sapiens_hsa04976 | 0.38836802 |
| 119 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37663832 |
| 120 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.36530570 |
| 121 | * N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33881096 |
| 122 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.32750392 |
| 123 | Lysosome_Homo sapiens_hsa04142 | 0.30711226 |
| 124 | Thyroid cancer_Homo sapiens_hsa05216 | 0.30479080 |
| 125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.30070993 |
| 126 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.29925673 |
| 127 | Prion diseases_Homo sapiens_hsa05020 | 0.25681488 |
| 128 | Insulin secretion_Homo sapiens_hsa04911 | 0.24833195 |
| 129 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.22500620 |
| 130 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.18207942 |
| 131 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.17221553 |
| 132 | Retinol metabolism_Homo sapiens_hsa00830 | 0.17219278 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.16079603 |
| 134 | Renin secretion_Homo sapiens_hsa04924 | 0.15355756 |
| 135 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.15211181 |
| 136 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.14091274 |

